Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma; Correction

---
identifier: "/us/fr/2012-2828"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2012-2828"
section_name: "Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma; Correction"
positive_law: false
currency: "2012-02-08"
last_updated: "2012-02-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-2828"
document_type: "rule"
publication_date: "2012-02-08"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 606"
  - "21 CFR Part 610"
  - "21 CFR Part 640"
fr_citation: "77 FR 6463"
fr_volume: 77
docket_ids:
  - "Docket No. FDA-2003-N-0097"
  - "Formerly 2003N-0211"
effective_date: "2012-07-02"
fr_action: "Final rule; correction."
---


#  Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Final rule; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the *Federal Register* of January 3, 2012. In the *Federal Register* of January 3, 2012, FDA published a final rule entitled “Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma,” which provided incorrect publication information regarding a 60-day notice that announced the availability of an opportunity for public comment on the proposed collection of certain information by FDA pertaining to the final rule. This document corrects this error. Elsewhere in this issue of the *Federal Register,* FDA is publishing a companion 60-day correction notice.

**DATES:**

This rule is effective July 2, 2012.

**FOR FURTHER INFORMATION CONTACT:**

Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 3208, Silver Spring, MD 20993-0002, (301) 796-9148.

**SUPPLEMENTARY INFORMATION:**

In the FR Doc. 2011-33554, appearing on page 7 in the *Federal Register* of Tuesday, January 3, 2012 (77 FR 7), the following correction is made:

1. On page 15, in the third column, in the third full paragraph, the first sentence is corrected to read: “To comply with section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)), FDA published a notice of proposed collection of information on December 30, 2011.” We are making this change because the notice of proposed collection inadvertently did not publish on January 3, 2012.

Dated: February 2, 2012.

Leslie Kux,

Acting Assistant Commissioner for Policy.